These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8878051)

  • 61. Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery.
    MacLean MR; Clayton RA; Templeton AG; Morecroft I
    Br J Pharmacol; 1996 Sep; 119(2):277-82. PubMed ID: 8886409
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase.
    Varrault A; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):367-74. PubMed ID: 1436121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex.
    Maura G; Thellung S; Andrioli GC; Ruelle A; Raiteri M
    J Neurochem; 1993 Mar; 60(3):1179-82. PubMed ID: 8382263
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.
    Dickenson JM; Hill SJ
    Br J Pharmacol; 1995 Dec; 116(7):2889-96. PubMed ID: 8680721
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A peripheral 5-HT1D-like receptor involved in serotonergic induced hindlimb scratching in rats.
    Berendsen HH; Broekkamp CL
    Eur J Pharmacol; 1991 Mar; 194(2-3):201-8. PubMed ID: 2060601
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
    Bouhelal R; Smounya L; Bockaert J
    Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
    Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
    Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype.
    Veldman SA; Bienkowski MJ
    Mol Pharmacol; 1992 Sep; 42(3):439-44. PubMed ID: 1328844
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
    Giles H; Lansdell SJ; Bolofo ML; Wilson HL; Martin GR
    Br J Pharmacol; 1996 Mar; 117(6):1119-26. PubMed ID: 8882605
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
    Assié MB; Cosi C; Koek W
    Eur J Pharmacol; 1999 Dec; 386(1):97-103. PubMed ID: 10611469
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors.
    Arthur JM; Casañas SJ; Raymond JR
    Biochem Pharmacol; 1993 Jun; 45(11):2337-41. PubMed ID: 8517875
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
    De Vivo M; Maayani S
    J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor.
    Wood M; Chaubey M; Atkinson P; Thomas DR
    Eur J Pharmacol; 2000 May; 396(1):1-8. PubMed ID: 10822046
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Operational characteristics of the 5-HT1-like receptors mediating external carotid vasoconstriction in vagosympathectomized dogs. Close resemblance to the 5-HT1D receptor subtype.
    Villalón CM; Sánchez-López A; Centurión D
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):550-6. PubMed ID: 8938651
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
    Becker BN; Gettys TW; Middleton JP; Olsen CL; Albers FJ; Lee SL; Fanburg BL; Raymond JR
    Mol Pharmacol; 1992 Nov; 42(5):817-25. PubMed ID: 1331764
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Activation of recombinant h 5-HT1B and h 5-HT1D receptors stably expressed in C6 glioma cells produces increases in Ca2+-dependent K+ current.
    Le Grand B; Panissié A; Pauwels PJ; John GW
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):608-15. PubMed ID: 9879718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.